Arkolith/Insider Trading/DNTH/Form 4

Soteropoulos Paula

DirectorDianthus Therapeutics, Inc. /DE/ (DNTH) · full profile →Form 4 · filed May 11, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$51K
Net Open-Market Flow
-$51K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 8, 2026Option exercise(M)599$8.44$5K599
May 8, 2026Sell(S)599$85.47$51K0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 8, 2026Option exercise(M)599—$00

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001692444-26-000008) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML